Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

During the Trading Day
1.31 +0.01 / +0.77%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.36 +0.05 / +3.82%
 
Volume: 444.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues6.5M5.5M6.3M5.7M
 
 
 
 
 
Cost of Goods Sold3.6M3.3M3.9M2.9M
 
 
 
 
 
Depreciation And Amortization249.0K277.0K265.0K261.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.6M1.9M2.2M2.6M
 
 
 
 
 
General Expenses13.2M15.1M14.3M15.6M
 
 
 
 
 
Research And Development8.8M10.2M10.0M11.3M
 
 
 
 
 
Total Operating Expenses17.0M18.7M18.4M18.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.5M-13.2M-12.1M-13.0M
 
 
 
 
 
Interest Expense On Debt0.000.000.001.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-13.1M-12.1M-13.0M
 
 
 
 
 
Preferred Dividend-401.0K-1.0M-1.0M-1.0M
 
 
 
 
 
Net Income-10.2M-13.1M-12.1M-13.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS177.3M179.1M180.0M182.5M
 
 
 
 
 
Shares To Calculate EPS Diluted177.3M179.1M180.0M182.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.08-$0.07-$0.08
 
 
 
 
 
EPS Diluted-$0.06-$0.08-$0.07-$0.08
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account